Article metrics

Download PDFPDF

399 Cosibelimab, an anti-PD-L1 antibody: preliminary safety and efficacy results from a global, multicohort phase 1 clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2020 to January 2024

AbstractFullPdf
Nov 2020145013
Dec 20203005
Jan 20213702
Feb 20215306
Mar 2021145025
Apr 202172014
May 202128013
Jun 2021007
Jul 20210010
Aug 20210011
Sep 20210018
Oct 202194028
Nov 2021358028
Dec 2021283014
Jan 2022118010
Feb 2022100010
Mar 202212404
Apr 20229204
May 202210406
Jun 2022110013
Jul 202214403
Aug 202210804
Sep 20229206
Oct 20228504
Nov 20226806
Dec 20225403
Jan 20236204
Feb 20235808
Mar 20233803
Apr 20233004
May 20235602
Jun 20233402
Jul 20234204
Aug 20234602
Sep 20232603
Oct 20232203
Nov 20234403
Dec 20237605
Jan 20241600
Total29940310